FDA to investigate delay responding to infant formula plant safety concerns
JURIST
MAY 17, 2022
US Food and Drug Administration (FDA) Commissioner Robert Califf Monday announced the agency will investigate the delay in dispatching investigators to the Abbott Nutrition infant formula plant in Michigan. This as Abbott Monday announced a plan to restart the Michigan plant in two weeks, in accordance with an FDA consent decree. The FDA and the Centers for Disease Control (CDC) initially launched an investigation into Abbott in late January 2022.
Let's personalize your content